Effect of Turmeric on Pruritus in Hemodialysis Patients

Sponsor
Shiraz University of Medical Sciences (Other)
Overall Status
Completed
CT.gov ID
NCT01037595
Collaborator
(none)
60
1
2
3
20.1

Study Details

Study Description

Brief Summary

The purpose of this study is to see whether turmeric can be effective in treatment of pruritus in hemodialysis patients.

Condition or Disease Intervention/Treatment Phase
Early Phase 1

Detailed Description

pruritus is a common in hemodialysis patients and many treatment recommended for it . as turmeric has anti-inflammatory , anti-cytokine and anti-oxidant effect it may effective in treatment of uremic pruritus. thus we compared turmeric with placebo in this study

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Oct 1, 2010
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: turmeric

turmeric 500 mg tid orally for 8 weeks

Drug: turmeric
turmeric 500 md tid orally for 8 weeks

Drug: turmeric
500 mg tid orally for 8 weeks

Placebo Comparator: plasebo

placebo tid orally for 8 weeks

Drug: placebo
placebo 3 time orally for 8 weeks

Outcome Measures

Primary Outcome Measures

  1. improvement in pruritus [6 mo]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Hemodialysis for more than 3 months

  • More than 18 years old

  • Pruritus

Exclusion Criteria:
  • Use other treatment for pruritus

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shiraz University Hemodialysis Center Shiraz Fars Iran, Islamic Republic of 098

Sponsors and Collaborators

  • Shiraz University of Medical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maryam Pakfetrat, associated professor of shiraz Shiraz University of Medical Sciences, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01037595
Other Study ID Numbers:
  • 3441
First Posted:
Dec 23, 2009
Last Update Posted:
May 14, 2013
Last Verified:
May 1, 2013
Keywords provided by Maryam Pakfetrat, associated professor of shiraz Shiraz University of Medical Sciences, Shiraz University of Medical Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2013